The motivation for this work stems from a specific incident in a production 16S rRNA gene sequencing pipeline. In this case, a step designed to remove chimeric sequences failed silently because a pinned version of the tool did not support a specific flag. An exception handler caught the error and simply copied the input to the output, allowing the pipeline to continue. Every log entry indicated success, and no exit codes were non-zero. However, chimeric reads, which accounted for a median of 11.9% of all reads across 48 samples, flowed directly into downstream denoising and classification steps. This single failure, along with three others of a similar character, demonstrated that conventional error handling is insufficient when the correct output is unknown and the pipeline does not announce its mistakes.

Ampliconaudit operates on the principle that the evidence needed to detect these failures already exists in the artifacts the pipeline writes, but it is rarely compared against expectations. The software runs after a pipeline completes and reads only these artifacts, such as log files, configuration records, and output tables. It does not reprocess the raw sequencing data, which keeps the audit process fast and cheap enough to run after every batch. The tool is built with a minimal dependency footprint, relying only on the Python standard library, ensuring it can be deployed in constrained environments without introducing complex dependency trees that might cause further compatibility issues.

The core of the tool consists of three distinct check classes, each designed to catch different types of silent failures. The first class, step contracts, asserts that a step left evidence of having actually run. This includes checking that required fields are present, that pinned parameters hold expected values, and that monotonic relations hold, such as a filter not emitting more records than it received. The second class, cohort invariants, looks for failures that are invisible in individual samples but obvious in aggregate. For example, if any sample in a cohort carries a high-identity BLAST hit, the species-level confirmations summed over the cohort cannot be zero. The third class, configuration-to-execution provenance, compares parameters computed from configuration against those actually passed to the executed call, catching cases where a parameter is logged but dropped before invocation.

To validate the tool, the authors performed an ablation study on a production pipeline using 48 human gut samples from three independent public studies and two mock community libraries. They created six experimental arms, each enabling or disabling specific repairs for the four identified failures. The results showed that the audit could not only detect that something was wrong but also attribute the fault to a specific step. For instance, when the chimera removal step was repaired, the step contract findings cleared, while the provenance findings remained. When the denoising parameters were repaired, the provenance findings cleared. This precise attribution allows researchers to pinpoint the source of degradation without having to manually inspect every log file.

The impact of these silent failures on biological results was substantial. In the baseline pipeline, species-level confirmations were running at roughly one-third of what the available evidence supported. After repairing the failures, species-level confirmations nearly tripled, increasing from a mean of 32.5 to 95.5 per sample. Additionally, the number of amplicon sequence variants (ASVs) decreased from 246.9 to 163.6 per sample, a reduction attributable to the removal of chimeric sequences. Interestingly, repairing the failures also made the pipeline faster, reducing the runtime for four samples by 17%. This speedup occurred because removing chimeric reads left fewer sequence variants for downstream denoising and classification, a saving that exceeded the cost of the reference scan.

The tool’s ability to detect errors was further tested against mock communities with known compositions. One of the mock libraries, Zymo.R2, contained eight declared genera. The audit showed that the repairs removed spurious variants without adding or losing any correct species calls. At the genus rank, the pipeline recovered all eight genera in every arm, and the Bray-Curtis distance between observed and declared proportions remained stable. This ground truth validation supports the claim that the audit detects real degradations rather than just statistical anomalies. The tool also identified a silent failure in a stock QIIME 2 workflow, where a truncation length discarded shorter reads in a specific study, demonstrating its applicability beyond the original production pipeline.

Despite its effectiveness, ampliconaudit has limitations. The profiles that define the checks are data-driven, meaning that adapting the tool to a new pipeline requires writing a new profile. While two profiles are bundled, one for a specific wrapper and one for stock QIIME 2 exports, independent deployment on other laboratories’ pipelines would strengthen the generality claim. Furthermore, the floor for the ratio invariant was calibrated on the ablation study, so its value on other pipelines and reference databases remains an open question. The audit detects violated expectations, not unanticipated failures, meaning that a failure mode that no one thought to express remains invisible. However, the three check classes narrow this gap significantly by formalizing what pipeline authors already believe must hold.

The development of ampliconaudit highlights a broader need for robust quality control in computational biology. As microbiome studies become more complex and integrated into clinical and dietary risk-assessment systems, the consequences of silent failures grow. A silently degraded taxonomic profile can propagate into every downstream model, leading to incorrect conclusions about health and disease. By making this class of failure addressable rather than merely acknowledged, ampliconaudit provides a practical solution that can be integrated into existing workflows with minimal overhead. The tool’s low cost, at just 70 milliseconds per cohort, makes it feasible to run as a mandatory post-condition of every run, ensuring that the integrity of biological data is maintained from the initial sequencing step to the final analysis.

Future work will focus on expanding the tool’s applicability to shotgun metagenomic pipelines and developing a declarative syntax for invariants that span more than two artifacts. The authors also plan to independently calibrate the confirmation-ratio floor to ensure its robustness across different datasets. As the field of microbiome research continues to grow, tools that ensure the reliability of computational pipelines will become increasingly important. Ampliconaudit represents a significant step forward in this direction, offering a rigorous, efficient, and accessible method for detecting the silent failures that can undermine scientific results. By turning expectations into executable assertions, it empowers researchers to trust their data with greater confidence, ultimately leading to more reproducible and accurate biological insights.

Subject of Research: Post-hoc detection of silent failures in amplicon taxonomic pipelines using artifact auditing

Article Title: ampliconaudit: post-hoc detection of silent failures in amplicon taxonomic pipelines

Article References: Nawalny, M., Sęk, I., Stroińska, B., Pasik, A., Matla, W., Tarnicki, L., Arct, B., Latkowski, T., Czerniak, J., Arct, J., Zakowicz, R., Pizon, M., Schott, D., & Kurek, J. (2026). ampliconaudit: post-hoc detection of silent failures in amplicon taxonomic pipelines. SoftwareX, 36, Article 103141. https://doi.org/10.1016/j.softx.2026.103141

Image Credits: AI Generated

DOI: 10.1016/j.softx.2026.103141

Keywords: amplicon sequencing, bioinformatics, software validation, microbiome analysis, silent failures, quality control, pipeline auditing, 16S rRNA, reproducibility, computational biology, ampliconaudit, post-hoc

The analysis, led by Xinru Wu and Tiancheng Yu with colleagues at Kunshan Integrated TCM and Western Medicine Hospital, Nanjing Tech University, Jiangsu Normal University and collaborating institutions, drew on two of the largest literature databases in science: the Web of Science Core Collection and Scopus. Searching from January 2015 to a cutoff of May 25, 2026, the team retrieved 702 qualifying articles from Web of Science and 334 from Scopus, restricting results to original research articles and reviews in English. They then processed this corpus with a suite of visualization tools — VOSviewer for collaboration and co-occurrence networks, CiteSpace for citation bursts, and the Bibliometrix package in R for knowledge maps — to reveal where the field has been and where it is heading.

The headline finding is a dramatic inflection point in publication output. Output remained modest between 2015 and 2018, with small year-to-year fluctuations, before entering a phase of rapid and sustained growth after 2019. Web of Science output peaked at 133 articles in 2025, while Scopus recorded 74 that year. The authors attribute the surge to several converging forces: the maturing of the gut-lung axis framework, the broad adoption of high-throughput sequencing and multi-omics technologies, and heightened interest in host-microbiome interactions during and after the COVID-19 pandemic. The apparently low numbers for 2026 simply reflect the partial-year search window rather than any slowdown.

Geographically, the field is strikingly concentrated. China led global output with 483 Web of Science publications — roughly 69 percent of the dataset — followed by the United States with 79. The pattern held in Scopus, where China accounted for 265 of 334 articles. At the institutional level, Fudan University topped both databases and emerged as the core hub of the collaboration network. Yet the study also flagged a notable weakness: international collaboration remains thin. Only about 5 to 6 percent of Chinese publications involved co-authors from multiple countries, compared with 19 to 32 percent for the United States, suggesting that despite China’s dominance in volume, the field’s collaborative fabric is still being woven.

Journal analysis revealed Frontiers in Immunology as the field’s central publication and citation hub, with 34 articles and 1,165 citations in the Web of Science dataset. Other productive outlets included Frontiers in Microbiology, Frontiers in Pharmacology, Journal of Ethnopharmacology and Frontiers in Cellular and Infection Microbiology, while highly cited nodes extended to PLoS ONE, Nature, the American Journal of Respiratory and Critical Care Medicine and Gut. The most influential individual papers spanned a remarkable range: a Science study on the microbial metabolite desaminotyrosine protecting against influenza through type I interferon signaling, a Nature Immunology paper on innate immune responses to trauma, and work on how gut microbiota modulates LPS-induced acute lung injury via the TLR4/NF-κB pathway. Citation-burst detection highlighted the strongest surges around papers on microbiota and the gut-lung axis, host defense against pneumococcal pneumonia, and, most recently, gut-lung crosstalk in sepsis-induced lung injury and microbiota-derived succinate aggravating injury after intestinal ischemia-reperfusion.

Keyword clustering distilled the field into a handful of coherent themes. Inflammation was the most frequent keyword, followed by microbiota, the gut-lung axis, mouse models and sepsis. The clusters pointed to gut-lung axis-mediated immune regulation, oxidative stress and inflammatory signaling, the protective functions of short-chain fatty acids, sepsis and critical illness-related injury, environmental exposure-induced microecological imbalance, and targeted interventions using probiotics and dietary strategies. Thematic evolution analysis showed a clear trajectory: early work from roughly 2017 to 2020 focused on intestinal permeability, mesenteric lymph and bacterial translocation; the middle phase from 2021 to 2023 shifted to dysbiosis and inflammatory pathway activation; and studies from 2024 onward have moved toward macrophage polarization, aryl hydrocarbon receptor-mediated immunometabolism, high-throughput sequencing and the hunt for clinical diagnostic biomarkers for acute respiratory distress syndrome.

The scientific rationale underlying this boom is compelling. Acute lung injury and its severe form, ARDS, affect roughly 86 people per 100,000 globally each year, and severe cases still carry mortality rates of 40 to 50 percent. Sepsis accounts for more than 60 percent of cases, and current treatments — lung-protective ventilation, fluid management, anti-infection therapy and glucocorticoids — remain largely supportive, with no drugs that specifically interrupt the core pathological cascade. Against this backdrop, the gut-lung axis offers an entirely new therapeutic entry point. Through the axis, gut microbes and their metabolites reach the circulation, immune cells migrate between mucosal sites, vagal signals travel between the organs, and, when the gut barrier fails, bacteria and their toxins translocate into the bloodstream.

Mechanistically, the field has converged on three hotspots. The first concerns how gut microbiota shapes the pulmonary immune microenvironment: intestinal CD103-positive dendritic cells secrete retinoic acid, programming lymphocytes with homing receptors that guide them to bronchus-associated lymphoid tissue and the alveolar interstitium, where they secrete IgA, interferon-gamma and interleukin-17, while gut-derived regulatory T cells produce IL-10 and TGF-beta to restrain excessive inflammation. When dysbiosis breaches the epithelial barrier, lipopolysaccharide enters the circulation, activates TLR4 and fans systemic inflammation that lands in the lungs. The second hotspot centers on short-chain fatty acids — acetate, propionate and butyrate produced by fiber fermentation — which dampen NF-κB and MAPK signaling through G protein-coupled receptors and histone deacetylase inhibition, push alveolar macrophages toward reparative M2 phenotypes, strengthen tight junctions via ZO-1 and occludin, protect the alveolar-capillary barrier, activate the Nrf2 antioxidant pathway and even slow pulmonary fibrosis by suppressing TGF-beta1/Smad signaling. The third involves microecological interventions, from Lactobacillus and Bifidobacterium strains that rebalance macrophage polarization to traditional Chinese medicine compounds such as ruscogenin and 8β-hydroxy-α-cyclocostunolide, whose mechanisms the authors note align strikingly with the ancient TCM principle that the lung and large intestine are interior-exterior related.

Clinical evidence is beginning to back the preclinical enthusiasm. Patients with ALI and ARDS consistently show severe gut dysbiosis — reduced microbial diversity, a shifted Firmicutes/Bacteroidetes ratio, depleted beneficial Bifidobacterium and Lactobacillus, and overgrowth of opportunists such as Escherichia coli — and the degree of dysbiosis correlates with oxygenation indices, inflammatory markers, ventilation duration and 28-day mortality. During the COVID-19 pandemic, certain probiotic strains were reported to reduce nasopharyngeal viral load and pulmonary inflammatory infiltration. Yet the bibliometric keyword analysis exposed the field’s central weakness: terms like nonhuman, animals, mouse model and animal experiment dominate the literature, particularly in the Scopus dataset where they topped the frequency tables.

The authors are candid about this gap. The principal deficit, they conclude, is not a shortage of candidate mechanisms but the limited validation of strain-specific, metabolite-specific and dose-dependent effects in standardized human studies. Probiotic efficacy varies by strain and dose, unified clinical criteria are lacking, and different causes of lung injury may demand individualized microbial strategies. They also acknowledge the limitations of their own approach — only two databases, English-language literature and restricted document types — which may bias trends and rankings. Still, the study offers researchers a clear map: the field has built its mechanistic foundations in animals, and the next decade’s challenge, the authors argue, lies in large-scale, multicenter randomized controlled trials, multi-omics biomarker discovery, and the careful translation of gut-lung axis science into precision interventions for the intensive care units where lung injury claims so many lives.

Subject of Research: Bibliometric mapping of gut microbiota and lung injury research from 2015 to 2026

Article Title: Research progress and trends of gut microbiota and lung injury: a bibliometric and visualization analysis based on two databases (2015–2026)

Article References: Wu, X., Yu, T., Hu, S., & Zhang, T. (2026). Research progress and trends of gut microbiota and lung injury: a bibliometric and visualization analysis based on two databases (2015–2026). Frontiers in Medicine, 13, Article 1902880. https://doi.org/10.3389/fmed.2026.1902880

Image Credits: AI Generated

DOI: 10.3389/fmed.2026.1902880

Keywords: gut microbiota, gut-lung axis, lung injury, acute respiratory distress syndrome, bibliometrics, short-chain fatty acids, probiotics, sepsis, traditional Chinese medicine, pulmonary immunity, inflammation, microbiome

The logic of the approach is elegantly simple. If a phage attacks only one host species, then adding that phage to a complex community is equivalent to performing a surgical deletion experiment: the targeted bacterium is depleted while the rest of the community, at least in principle, remains untouched. Any subsequent changes in the abundance or behavior of other members can then be attributed to the loss of the depleted organism, providing the kind of causal evidence that observational metagenomics alone cannot deliver. Despite this potential, phages have rarely been harnessed for this purpose, largely because isolating viruses with sufficiently narrow host ranges against ecologically relevant bacteria has been a technical bottleneck.

Hessler and colleagues overcame that bottleneck for the bacterial genus Variovorax, a group of soil and rhizosphere bacteria that has emerged as a key player in plant-associated communities. The team isolated nine phages that replicate in several ecologically important Variovorax species. Host-range testing showed that these viruses are strikingly specific: spot assays across multiple Variovorax strains revealed that only one of the nine phages, V45_66, was able to form plaques on more than a single host. That narrow specificity is precisely what makes the phages useful as experimental scalpels, since a broad-host-range virus would trigger cascading effects that would confound the interpretation of any community-level changes.

The researchers’ first test case came from a long-standing hypothesis about vitamin sharing. Variovorax had been predicted, on the basis of correlation network analyses, to engage in thiamine interdependencies with other community members—meaning that some organisms might rely on Variovorax to supply this essential B vitamin, or vice versa. To test this, the team worked with complex enrichment communities containing between 18 and 31 bacterial species, grown in the laboratory on different carbon sources including guar gum, locust bean gum, arabinogalactan, and konjac gum. These communities were allowed to stabilize over repeated passages, with pairwise Bray–Curtis dissimilarity analysis showing that their composition settled into a steady state by day eight to ten of the experiment.

Into these stabilized communities, the researchers introduced three of their Variovorax-specific phages, either individually or as a cocktail, targeting a strain designated Variovorax SCN45. Genome-resolved metagenomics—a technique that reconstructs the genomes of individual community members from mixed sequencing data and tracks their relative abundances over time—revealed a consistent reduction in Variovorax across all four enrichment cultures following phage application. Crucially, the depletion did not stop with Variovorax. One other population, a bacterium belonging to the genus Leifsonia, declined in relative abundance once its putative partner was gone, exactly as the correlation-based hypothesis of thiamine interdependence had predicted.

The decisive experiment came next. If Leifsonia was collapsing because it had lost access to Variovorax-produced thiamine, then simply adding thiamine to the culture should rescue it. That is precisely what the researchers observed: supplementation with 10 milligrams per liter of thiamine restored the Leifsonia population. Differential abundance screening, combined with statistical testing across the pre-phage, post-phage, and post-phage-plus-thiamine conditions, identified the Leifsonia population and two members of the family Microbacteriaceae as likely dependents on Variovorax-derived thiamine. Metagenome-assembled genome data for Leifsonia were consistent with the amplicon sequence variant analysis, and gene fitness profiling by RB-TnSeq showed that Variovorax SCN45 carries a complete thiamine biosynthesis operon alongside a type IV secretion system, both of which were highlighted in the community context. Together, these lines of evidence confirmed thiamine production as the mechanistic basis for the interdependence between Variovorax and Leifsonia, converting a statistical association into a verified biochemical relationship.

The team then extended the approach to a second, entirely different experimental system: a defined rhizosphere co-culture grown with Arabidopsis plants. In this system, a strain called Variovorax CL14 is known to degrade the plant hormone auxin produced by another bacterium, Arthrobacter CL28. Auxin is a central regulator of plant growth, and its degradation by Variovorax modulates how the plant responds to its microbial residents. Using phages v.cl_11 and v.cl_23, the researchers eliminated Variovorax CL14 from the co-culture. The result was a re-establishment of the stunted root phenotype, demonstrating that removing the auxin-degrading bacterium allowed the hormone to accumulate and suppress root growth. Growth curve experiments confirmed that the phages had no direct effect on Arthrobacter CL28 itself, reinforcing the specificity of the manipulation.

Beyond the specific findings about thiamine and auxin, the study carries a broader methodological significance. The enrichment communities in the experiments were monitored for stability, and haplotype frequency analysis was used to track evolutionary changes associated with phage exposure, giving the researchers a window into both ecological and evolutionary responses to viral attack. Supplementary analyses showed that the summed relative abundance of organisms encoding complete thiamine biosynthesis pathways shifted predictably across the experimental stages, and that the phage-induced perturbations were reproducible across independent carbon-source enrichments. This level of internal consistency strengthens the case that phage-mediated depletion can serve as a general-purpose tool for causal inference in microbiome science, complementing approaches such as gnotobiotic reconstruction, metabolic modeling, and isotope tracing.

The implications reach well beyond the laboratory. Microbiomes govern processes of enormous practical importance—from nutrient cycling in soils and plant health in agriculture to the functioning of bioreactors and, in medicine, the balance of human gut communities. A technique that allows researchers to remove a single species from a functioning community and observe the consequences could accelerate the identification of keystone organisms, the validation of cross-feeding networks, and ultimately the rational design of synthetic microbial consortia. The authors note that their experiments lay the foundation for research employing both wildtype and engineered phages to test interaction hypotheses and for targeted microbiome manipulation. Engineered phages, in particular, could in principle be designed to deliver payloads or to tune depletion dynamics with even finer control.

There are, of course, caveats and open questions. Phage infection itself can trigger physiological changes in the target host before lysis, and phage replication may impose selection pressure on the community, as suggested by the haplotype dynamics observed in this study. Host-range specificity, while an asset here, must be established case by case, and not every ecologically important bacterium has a culturable phage. Nevertheless, the demonstration that nine narrow-host-range phages could be isolated against Variovorax, and that three of them could cleanly test a metabolic interdependence hypothesis inside communities of up to 31 species, marks a substantial advance. The work, supported by the U.S. Department of Energy’s m-CAFEs Science Focus Area at Lawrence Berkeley National Laboratory, suggests a future in which viruses—long studied as pathogens of bacteria—become routine instruments for dissecting the hidden wiring of microbial ecosystems, one species at a time.

Subject of Research: Phage-based depletion of Variovorax to test microbial interactions in intact microbiomes

Article Title: Phage-based depletion of Variovorax reveals interactions within intact microbiomes

Article References: Hessler, T., Chiniquy, D., Adler, B. A., Hoff, J., Tucker, E., Huddy, R. J., Sachdeva, R., Lei, S., Harrison, S. T. L., Barrangou, R., Diamond, S., Deutschbauer, A. M., & Banfield, J. F. (2026). Phage-based depletion of Variovorax reveals interactions within intact microbiomes. Microbiome. https://doi.org/10.1186/s40168-026-02539-x

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02539-x

Keywords: bacteriophages, microbiome, Variovorax, thiamine, cross-feeding, metagenomics, rhizosphere, Arabidopsis, auxin, Leifsonia, microbial interactions, phage therapy